Table 3c Vital status after the start of follow-up, which is at the date of mutation testing or the date of CPM

From: Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers

Outcome and follow-up

CPM group ( N =79)

Surveillance group ( N =69)

P -value

Follow-up mean±s.e. (years)

 Until death or end of follow-up

3.4±0.2

3.7±0.2

0.337

Vital status, N (%) (sum of Table 3a )

  

0.021

 Alive

76 (96.2)

58 (84.1)

 

 Deceased

3 (3.8)

11 (15.9)

 
  1. CPM=contralateral prophylactic mastectomy; s.e.=standard error of the mean.
Back to article page